Cerity Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Buy
28,365
+18,214
+179% +$89.3K ﹤0.01% 3078
2026
Q1
$34.7K Buy
+10,151
New +$34.2K ﹤0.01% 3145

Other funds holding ASPN

Cerity Partners's ASPN Position: Q2 2026 in Review

Cerity Partners increased its Aspen Aerogels (ASPN) stake by 179% in Q2 2026, buying an estimated $89.3K and bringing the position to 28,365 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3078.

Cerity Partners first reported a position in ASPN in Q1 2026 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Cerity Partners held 28,365 shares of Aspen Aerogels worth $180K as of Q2 2026.
  • Cerity Partners bought 18,214 Aspen Aerogels shares in Q2 2026, an estimated $89.3K.
  • Aspen Aerogels made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3078 holding.
  • Cerity Partners first reported a position in Aspen Aerogels in Q1 2026 and has held it in 2 quarters since.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.